SRI Int'l to Support Anti-Cancer Vaccine Studies for NIH Center

SRI Int'l to Support Anti-Cancer Vaccine Studies for NIH Center

Health research management SRI International will carry out pre-clinical studies on compounds and vaccines to determine if they can act as preventive agents against cancer under a $19.8 million contract with a National Institutes of Health center.

(Visited 1 times, 1 visits today)
14
Like
Save

Comments

Comments are disabled for this post.